Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
British Journal of Haematology (2017)
  • Andrew J. Cowan, University of Washington
  • Phillip A. Stevenson
  • Ted A. Gooley, University of Washington
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • George R. Oliveira, Harvard University
  • Stephen D. Smith, Cancer Institute
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Jennifer E. Roden, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, University of Washington
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, University of Washington
Link
Disciplines
Publication Date
January 2, 2017
DOI
10.1111/bjh.14451
Citation Information
Andrew J. Cowan, Phillip A. Stevenson, Ted A. Gooley, Shani L. Frayo, et al.. "Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma." British Journal of Haematology Vol. 176 Iss. 4 (2017) p. 583 - 590
Available at: http://works.bepress.com/john-pagel/28/